Regulatory affairs department of EPPL serves as the interface between the regulatory authority and the project team, and is the channel of communication with the regulatory authority as the project proceeds, aiming to ensure that the project plan correctly anticipates what the regulatory authority will require before approving the product.
Our Regulatory Affairs (RA) professionals play critical roles because it is concerned about the healthcare product lifecycle, it provides strategic, tactical, and operational direction and support for working within regulations to expedite the development and delivery of safe and effective healthcare products to individuals in the country.
The RA department reviews all documentation from a regulatory perspective, ensuring that it is clear, consistent, and complete and that its conclusions are explicit. The department also drafts the core prescribing information that is the basis for approval, and will later provide the platform for marketing.